Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Avista Healthcare Partners has acquired sanotact Group, a medical devices business in Germany, for $1.0 billion. sanotact Group manufactures medical device components and systems used in healthcare settings, supporting Avista Healthcare Partners acquisitions in the medical devices acquisition market. Avista Healthcare Partners seeks platform acquisition scale in German manufacturing to expand its healthcare M&A footprint through private equity acquisition. The announced platform acquisition is backed by a private equity buyer and is expected to close after customary approvals, with deal terms positioned to grow the sanotact Group platform within Avista’s portfolio.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026